Skip to Content

MYLAN 1261 MYLAN 1261 (Propafenone hydrochloride extended-release 425 mg)

Pill imprint MYLAN 1261 MYLAN 1261 has been identified as Propafenone hydrochloride extended-release 425 mg.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substance Act (CSA).

Propafenone hydrochloride extended-release 425 mg MYLAN 1261 MYLAN 1261
Discount Card Promo
Propafenone hydrochloride extended-release
Imprint:
MYLAN 1261 MYLAN 1261
Strength:
425 mg
Color:
Red / Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide